Pulm Clin Med Quick Hits - Maddie PDF

Document Details

BoundlessObsidian4130

Uploaded by BoundlessObsidian4130

Maddie

Tags

pulmonary medicine respiratory conditions

Summary

This document appears to be a collection of quick reference notes or summaries of pulmonary conditions, likely intended for medical use or study. It includes conditions such as chronic asthma, acute asthma, COPD, as well as other respiratory-related topics and information.

Full Transcript

‭Condition‬ ‭Dx‬ ‭Tx‬ ‭Other info, key words‬ ‭Chronic Asthma‬ ‭ pirometry -‬ S ‭obstructive pattern,‬ ‭Decreased FEV1 and‬ ‭FVC‬ ‭ ABA - albuterol‬ S ‭LABA - Formoterol‬ ‭Bronchodilators:‬ ‭SAMA and LAMA‬ ‭ topic triad (rhinitis,‬ A ‭eczema, dermatitis)‬ ‭ ronchodilator‬ B ‭challenge‬ ‭ amters tria...

‭Condition‬ ‭Dx‬ ‭Tx‬ ‭Other info, key words‬ ‭Chronic Asthma‬ ‭ pirometry -‬ S ‭obstructive pattern,‬ ‭Decreased FEV1 and‬ ‭FVC‬ ‭ ABA - albuterol‬ S ‭LABA - Formoterol‬ ‭Bronchodilators:‬ ‭SAMA and LAMA‬ ‭ topic triad (rhinitis,‬ A ‭eczema, dermatitis)‬ ‭ ronchodilator‬ B ‭challenge‬ ‭ amters triad (nasal‬ S ‭polyps, asthma,‬ ‭aspirin sensitivity)‬ ‭ VC/FEV1 is‬ F ‭normal→‬ ‭methacholine‬ ‭challenge‬ ‭Acute asthma‬ ‭Peak Flow Rate‬ ‭ lbuterol‬ A ‭Ipratropium - Steroid‬ ‭- Sink‬ ‭Montelukast‬ ‭ rouble breathing‬ T ‭Cough that's worse at‬ ‭night‬ ‭Dyspnea‬ ‭Wheezing on‬ ‭expiration‬ ‭Triggers‬ ‭Status Asthmaticus‬ ‭ oesn’t improve with‬ D ‭meds‬ ‭ ronchodilators‬ B ‭Mag (IV)‬ ‭Epinephrine‬ ‭intubate/‬ ‭MechanicalVentilation‬ ‭ cute severe asthma‬ A ‭that does not improve‬ ‭w/usual doses of‬ ‭bronchodilators &‬ ‭steroids‬ ‭COPD‬ ‭ XR / Spirometry‬ C ‭Sputum Culture‬ ‭O2‬ ‭Screen for alpha1‬ ‭antitrypsin deficiency‬ ‭ ong term‬ L ‭Stop smoking‬ ‭SABA and LABA‬ ‭SAMA and LAMA‬ “‭ Occupational‬ ‭hazards” “tobacco‬ ‭exposure”‬ ‭ requent‬ F ‭exacerbations -‬ ‭steroids‬ ‭ OPD acute‬ C ‭exacerbation‬ ‭PFTs‬ ‭CXR‬ ‭ ost are viral, but if it‬ M ‭has cardinal‬ ‭symptoms that‬ ‭require ventilation -‬ ‭antibiotics‬ ‭(augmentin) q5‬ ‭O2‬ ‭Steroid‬ ‭ ay have chest wall‬ M ‭abnormalities or‬ ‭flattened diaphragm‬ ‭ ducation don’ts:‬ E ‭DON'T adjust your‬ ‭medicines (including‬ ‭oxygen) without first‬ ‭talking with your‬ ‭provider‬ ‭→ DON'T go outside‬ ‭or exercise if air is‬ ‭polluted or if the air‬ ‭quality index is poor‬ ‭→ DON'T spend lot of‬ ‭COPD bronchitis‬ ‭ FTs gold standard‬ P ‭(decreased FEV1‬ ‭and FVC ‬ ‭3mo in each 2 years”‬ ‭Peripheral edema‬ ‭ ore symptoms +‬ M ‭low risk: LAMA or‬ ‭LABA + SABA‬ ‭ inimally‬ M ‭symptomatic daily:‬ ‭LAMA +/- LABA‬ ‭ igher sx burden:‬ H ‭LAMA+LABA +/-‬ ‭inhaled steroid‬ ‭COPD emphysema‬ ‭ FTs: gold standard‬ P ‭5 days‬ ‭ hildren: increased‬ C ‭fluid, honey,‬ ‭antipyretics, oral‬ ‭analgesics‬ ‭ RIsx, malaise,‬ U ‭dyspnea, wheezing,‬ ‭hemoptysis‬ ‭Fever is rare‬ ‭Epiglottitis‬ ‭Croup‬ ‭Laryngoscopy‬ ‭Airway management‬ ‭XR→ thumb sign‬ ‭ BX ceftriaxone/‬ A ‭cefotaxime or vanco‬ ‭Tripod position‬ ‭Vaccines (HIB)‬ ‭Cherry red epiglottis‬ ‭ examethasone.6‬ D ‭mg/kg‬ ‭Racemic epi in‬ ‭children w/ sever‬ ‭symptoms‬ ‭ arking cough‬ B ‭usually at night,‬ ‭stridor, use of‬ ‭accessory muscles‬ ‭CXR: steeple sign‬ ‭ ysphagia, drooling,‬ D ‭distress‬ ‭Parainfluenza‬ I‭diopathic Pulmonary‬ ‭fibrosis‬ ‭Lung Biopsy‬ ‭ XR - peripheral‬ C ‭honeycombing‬ ‭ T scan - patchy‬ C ‭peripheral reticular‬ ‭abnormalities with‬ ‭intralobular linear‬ ‭opacities, thick‬ ‭septum, subpleural‬ ‭honeycombing,‬ ‭ground- glass‬ ‭opacities‬ ‭Sarcoidosis‬ ‭CXR‬ ‭ ulm. function tests -‬ P ‭restrictive pattern‬ ‭Inc. ACE level‬ ‭PFT: inc. FEV1/FVC‬ ‭ nti fibrotic -‬ A ‭pirfenidone‬ ‭ yrosine kinase‬ T ‭inhibitor - nintedanib‬ ‭ 6 months of‬ > ‭exertional dyspnea,‬ ‭nonproductive cough‬ I‭nspiratory crackles‬ ‭“velcro”‬ ‭Lung transplant‬ ‭Clubbing‬ ‭ reat when organ‬ T ‭ C in African‬ M ‭function is threatened‬ ‭American Women‬ ‭- corticosteroids‬ ‭50% are non‬ ‭Progressive -‬ ‭symptomatic‬ ‭methotrexate‬ ‭(immunosuppressant)‬ ‭Dry nonproductive‬ ‭cough, rales,‬ ‭dyspnea‬ ‭ iopsy- non-casing‬ B ‭granuloma‬ ‭Erythema nodosum‬ ‭Lupus pernio‬ ‭Uveitis‬ ‭Cor Pulmonale‬ ‭EKG: S1Q3T3‬ ‭ECHO‬ ‭ xygen to correct‬ O ‭hypoxia (goal 90%)‬ ‭ tiology: Caused‬ E ‭COPD, pulm‬ ‭embolism, ARDS‬ ‭ odium and fluid‬ S ‭restriction‬ ‭ ow level aerobic‬ L ‭exercise‬ ‭ ower extremity‬ L ‭edema, neck vein‬ ‭distension,‬ ‭hepatomegaly, loud‬ ‭S2‬ ‭Tx underlying‬ ‭ IURETICS NOT‬ D ‭HELPFUL‬ ‭Pulmonary HTN‬ ‭ ight heart‬ R ‭catheterization (gold‬ ‭standard)‬ ‭ XR‬ C ‭ECHO‬ ‭ECG‬ ‭CMR‬ ‭PFT‬ ‭Remain active‬ ‭Exertional dyspnea‬ I‭dentify and tx‬ ‭underlying‬ ‭ norexia /abdominal‬ a ‭pain‬ ‭Vasoreactivity: CCB‬ ‭Insidious‬ ‭Diuretics‬ ‭Hoarse voice‬ ‭ rostanoids and‬ P ‭PDE5‬ ‭Hemoptysis‬ ‭Dig‬ ‭ olosystolic tricuspid‬ H ‭regurg‬ ‭Heart-lung transplant‬ ‭Pulmonary embolism‬ ‭Well’s criteria‬ ‭Heparin‬ ‭Homan’s sign (DVT)‬ ‭ a inhibitors‬ X ‭(coumadin)‬ ‭D-Dimer‬ ‭Stable: anticoagulant‬ ‭ ulmonary‬ P ‭angiography is the‬ ‭gold standard‬ ‭ nstable:‬ U ‭thrombolysis and‬ ‭thrombectomy/embol‬ ‭ectomy‬ ‭ yspnea sudden‬ D ‭onset*‬ ‭Tachypnea‬ ‭Cough‬ ‭Weezing‬ ‭Chest pain pleuritic*‬ ‭Syncope‬ ‭Fever, diaphoresis‬ ‭Hemoptysis*‬ ‭Evidence of DVT‬ I‭ncreased pulmonic‬ ‭component of S2‬ ‭murmur. Right‬ ‭ventricular heave‬ ‭Friction rub‬ ‭ cute respiratory‬ A ‭distress syndrome‬ ‭(failure)‬ ‭ECHO‬ ‭Low tidal volume‬ ‭Bronchoscopy‬ ‭Noninvasive or‬ ‭ yspnea‬ D ‭Anxiety, paradoxical‬ ‭breathing and use of‬ ‭mechanical‬ ‭ OCUS (point of care‬ v P ‭ entilation → ICU‬ ‭ultrasound)‬ ‭Tx underlying‬ ‭ ccessory muscles‬ a ‭Coarse crepitations‬ ‭or crackles in BOTH‬ ‭lungs‬ ‭Low tidal volume‬ ‭ EEP: improve‬ P ‭hypoxemia‬ ‭Cystic fibrosis‬ ‭ weat chloride test‬ S ‭(most accurate)‬ ‭ XR‬ C ‭PFTs‬ ‭DNA testing‬ ‭ BX (macrolides,‬ A ‭cephalosporins,‬ ‭augmentin,‬ ‭fluoroquinolones,‬ ‭ ucus clearance‬ M ‭mucolytics‬ ‭ FTR dysfunction on‬ C ‭2+ studies‬ ‭ ronchodilators with‬ B ‭airflow obstruction‬ ‭Mutation CFTR gene‬ ‭ ffect GI, pancreas,‬ A ‭lungs, reproductive‬ ‭systems‬ ‭(infertility in men),‬ ‭greasy stool, clubbing‬ ‭Common pneumonia‬ ‭ urulent sputum -‬ P ‭Long-term pancreatic‬ ‭most common‬ ‭enzyme replacement‬ ‭pseudos‬ ‭Bronchiectasis‬ ‭PFTs‬ ‭Augmentin‬ ‭CXR‬ ‭Postural drainage‬ ‭ T scan of the chest‬ C ‭has become the best‬ ‭tool to detect cystic‬ ‭lesions - ring sign,‬ ‭tramtrack‬ ‭appearance‬ ‭Vibrating vest‬ ‭ ost commonly‬ M ‭caused by cystic‬ ‭fibrosis + pseudo‬ ‭ oist crackles at lung‬ M ‭bases‬ (‭ main goal is mucus‬ ‭clearance)‬ ‭Purulent sputum‬ ‭vaccinations‬ ‭Hemoptysis‬ ‭Halitosis‬ ‭ oreign body‬ F ‭aspiration‬ ‭CXR‬ ‭ T is CXR is‬ C ‭negative‬ I‭nfants less than 1‬ ‭given 5 chest‬ ‭compression‬ ‭alternated with 5‬ ‭blows between‬ ‭scapula‬ ‭ brupt onset of‬ A ‭respiratory distress in‬ ‭a child‬ ‭Adults→ heimlich‬ ‭ olalize/cough→‬ v ‭partial obstruction‬ ‭ hoking, striador,‬ C ‭drooling‬ ‭Rigid bronchoscopy‬ ‭ ollowing removal→‬ F ‭nebulizer treatments‬ ‭ ower: cough,‬ L ‭wheezing, decreased‬ ‭breath sounds‬ ‭ nilateral wheezing‬ U ‭or breath sounds‬ ‭ yaline membrane‬ H ‭disease (respiratory‬ ‭distress syndrome)‬ ‭ XR→ Ground glass‬ C ‭appearance‬ ‭ other→ antenatal‬ M ‭steroids‬ ‭(betamethasone)‬ ‭ espiratory distress‬ R ‭in a premature‬ ‭newborn‬ ‭CPAP for baby‬ ‭ asal flaring,‬ N ‭tachypnea, cyanosis,‬ ‭expiratory grunting‬ ‭and retractions‬ I‭nterstitial lung‬ ‭disease‬ ‭ iopsy (best)->‬ B ‭CT->XR (done first)‬ ‭CXR: eggshell‬ ‭calcifications upper‬ ‭lobes‬ ‭ orticoid steroids,‬ C ‭supportive care,‬ ‭vaccinations‬ “‭ Coal workers” -‬ ‭occupational hazards‬ ‭Shaggy heart sign‬ ‭ ilicosis - rocks and‬ S ‭eggshell‬ ‭ ulmonary function‬ P ‭testing will show a‬ ‭restrictive pattern:‬ ‭decreased FEV1,‬ ‭FVC, TLC, and‬ ‭residual volume‬ ‭ yssinosis - textile‬ b ‭factory workers‬ ‭ eriliosis - aerospace‬ B ‭and electronics‬ ‭ sbestos- broken‬ A ‭down buildings‬ ‭Carcinoid tumor‬ ‭Lung cancer‬ ‭ ronchoscopy‬ B ‭Biopsy‬ ‭Biopsy - histology‬ ‭ urgical removal,‬ S ‭cytotoxic chemo‬ ‭ ctreotide and‬ O ‭sandostatin‬ ‭ ed, purple flushes‬ R ‭starting in the face‬ ‭and spread to the‬ ‭neck and truck,‬ ‭tricuspid insufficiency‬ ‭ urgical removal,‬ S ‭chemotherapy‬ ‭ hest, shoulder, and‬ C ‭bone pain‬ ‭CXR‬ ‭ ET superior for‬ P ‭NSCLC‬ ‭ orner Syndrom:‬ H ‭constricted pupil,‬ ‭ptosis, facial‬ ‭anhidrosis‬ ‭ ronchogenic,‬ B ‭adenocarcinoma,‬ ‭SCC, small cell oat‬ ‭cell‬ ‭Pulmonary nodules‬ ‭CXR‬ ‭ T - likelihood of‬ C ‭malignancy of‬ ‭modules‬ ‭ ow - active‬ L ‭surveillance‬ ‭ oin shaped lesions,‬ C ‭usually an incidental‬ ‭finding‬ ‭ edium -‬ M ‭bronchoscopy needle‬ S ‭ piculated irregular‬ ‭aspiration‬ ‭borders‬ ‭PET scan‬ ‭High - resection‬ ‭Biopsy if > 8mm‬ ‭Influenza‬ ‭ iral culture, rapid‬ V ‭test (RIDT)‬ ‭ ed rest, hydration,‬ B ‭antipyretics‬ ‭ brupt onset of fever,‬ A ‭myalgias, headache‬ ‭ igh risk pt can be‬ H ‭given oseltamivir,‬ ‭zanamivir, or‬ ‭baloxavir‬ ‭Pertussis‬ ‭ neumonia‬ P ‭(bacterial)‬ ‭ CR most sensitive‬ P ‭method‬ ‭ accination‬ V ‭prevention‬ ‭ lood cultures‬ B ‭CXR‬ ‭CBC‬ ‭Supportive care‬ ‭ XR‬ C ‭CBC‬ ‭Blood cultures‬ ‭ moxicillin, cefdinir,‬ A ‭doxy‬ ‭ osttussive emesis‬ P ‭or/and inspiratory‬ ‭whoop‬ ‭ BX indicated‬ A ‭(azithromycin,‬ ‭erythromycin,‬ ‭TMP-SMX)‬ ‭ ith comorbidities:‬ W ‭macrolide or‬ ‭doxycycline + amox-‬ ‭clav or cefdinir‬ ‭ igh fever, chills,‬ H ‭insidious onset, rusty‬ ‭sputum‬ ‭(mycoplasma)‬ ‭ egionella: high‬ L ‭fever, mental status‬ ‭change‬ I‭npatient:‬ ‭fluoroquinolone‬ ‭Steroids‬ ‭TB‬ ‭CXR (primary)‬ ‭ eactivation ( apical‬ R ‭caviatary lesion,‬ ‭sputum smears or‬ ‭tissue culture‬ ‭ atent: TST skin test‬ L ‭>15mm no known RF‬ ‭ IPE! With vitamin B‬ R ‭6‬ ‭ ycobacterium TB,‬ M ‭airborne‬ ‭HIV pt‬ ‭ rimarily:‬ P ‭asymptomatic‬ ‭HIV→ fever, night‬ ‭ 10MM Immigrant,‬ > ‭ive drug use,‬ ‭>5mm HIV, recent‬ ‭contact‬ ‭Viral pneumonia‬ ‭sweats‬ ‭ CR test (COVID,‬ P ‭flu,, rsv)‬ ‭ OVID- supportive or‬ P C ‭ resence of‬ ‭remdesivir/ steroid‬ ‭epidemic/pandemic‬ ‭Sputum gram stain‬ ‭Flu- tamiflu‬ ‭ XR(generalized‬ C ‭interstitial opacities)‬ ‭RSV- ribavirin‬ ‭ OVID, Influenza,‬ C ‭RSV,‬ ‭metapneumovirus‬ ‭Fever, SOB, cough‬ ‭ naerobic pulmonary‬ A A ‭ naerobic culture‬ ‭infections‬ ‭Blood culture‬ ‭US‬ ‭CT‬ ‭ rainage of abscess‬ D ‭(CT guided)‬ ‭Oral ABX‬ ‭(clindamycin)‬ ‭ ecrotizing‬ N ‭pneumonia,‬ ‭empyema, lung‬ ‭abscess‬ ‭Lung abscess‬ ‭ xygen‬ O ‭ABX (piper tazo‬ ‭ampicillin- sulbactam‬ ‭3 g IV Q 6‬ I‭ncreased risk of‬ ‭periodontal disease‬ ‭ BC/ sputum‬ C ‭CXR‬ ‭ djust ABX after‬ A ‭sputum culture‬ ‭comes back‬ ‭ oul odor sputum‬ F ‭Dullness to‬ ‭percussion,‬ ‭whispered‬ ‭pectoriloquy, and‬ ‭bronchophony‬ ‭amphoric breath‬ ‭sounds (low pitched )‬ ‭Aspiration!‬ ‭Fungal pneumonia‬ ‭ XR. Doesnt mention‬ P C ‭ JP/PCP‬ ‭anything about DX‬ ‭(TMP-SMX)‬ ‭same as pneumonia‬ ‭Aspergillus (Ampho‬ ‭B, Voriconizole)‬ ‭ ryptococcus‬ C ‭(ampho B,‬ ‭fluconazole)‬ ‭ andida‬ C ‭(caspofungin)‬ ‭ JP: marked‬ P ‭hypoxia, dyspnea,‬ ‭and cough with a‬ ‭paucity of physical or‬ ‭radiologic findings‬ ‭Covid 19‬ ‭PCR rapid test‬ ‭ pparent distress→‬ A ‭immediate‬ ‭Lab tests (secondary)‬ ‭assessment of ABC‬ ‭ ral antiviral‬ O ‭*(paxlovid)‬ ‭Steriods‬ ‭Can be asymptomatic‬ ‭ ild: no or mild‬ M ‭pneumonia‬ ‭ evere: dyspnea,‬ S ‭hypoxia or >50% lung‬ ‭involvement‬ ‭ oss of smell or‬ L ‭taste, GI‬ ‭manifestations‬ ‭“appear quite ill”‬ “‭ Silent” (or happy)‬ ‭hypoxemia‬ ‭ hilblain like acral‬ C ‭lesion‬ ‭Pleurisy‬ ‭ nti-glomerular‬ A ‭basement membrane‬ ‭disease‬ ‭(Goodpasture)‬ ‭ KG,‬ E ‭CBC‬ ‭D-dimer‬ ‭CXR‬ ‭CT‬ ‭ SAIDS +/-‬ N ‭indomethacin‬ ‭ leuritic chest pain‬ P ‭worsens with‬ ‭respiration‬ ‭ nti-GBM antibodies‬ a ‭Kidney biopsy w/light‬ ‭microscopy, w/ linear‬ ‭IgG staining‬ ‭ x emergently before‬ 3 T ‭ rd decade of life‬ ‭confirming dx‬ ‭then again at 6-7th‬ ‭decade‬ ‭Therapeutic plasma‬ ‭exchange daily for 2‬ ‭Onset may be‬ ‭weeks‬ ‭preceded by URI‬ ‭Pleural friction rub‬ ‭ orticosteroids and‬ C ‭cyclophosphamide‬ ‭ ranulomatosis w/‬ G ‭ x not suspected‬ D ‭polyangiitis (Wegener‬ ‭until systemic sx‬ ‭granulomatosis)‬ ‭develop‬ ‭Fatal without tx‬ i‭nduction : rituximab‬ ‭+ prednisone (first‬ ‭Labs: serum test‬ ‭line) , long term use‬ ‭(ANCA) 80-90% seen‬ ‭of cyclophosphamide‬ ‭increase cancer risk‬ ‭Cytoplasmic ANCA‬ ‭(can get PML with‬ ‭→ proteinase 3‬ ‭rituximab and‬ ‭cyclophosphamide)‬ ‭Perinuclear ANCAA‬ ‭→ myeloperoxidase‬ ‭Maintenance:‬ ‭rituximab‬ ‭CT‬ ‭ ecrotizing‬ N ‭granulomatous‬ ‭lesions on upper and‬ ‭lower resp. Tract‬ I‭nflammation caused‬ ‭by ANCA‬ ‭ RI sx, lung affected‬ U ‭(cough, hemoptysis)‬ ‭Renal involvement‬ ‭“Saddle nose”‬ ‭ x confirmation by‬ D ‭tissue biopsy‬ ‭ rbital involvement‬ O ‭leads to devastating‬ ‭morbidity and‬ ‭mortality‬ ‭ osinophilic‬ E ‭granulomatosis‬ ‭(Churg Strauss‬ ‭syndrome)‬ ‭ANCA testing‬ ‭ orticosteroids first‬ C ‭line‬ ‭ atients with‬ P ‭unexplained‬ ‭eosinophilia and‬ ‭vasculitis‬ ‭ iffuse alveolar‬ D ‭hemorrhage‬ ‭ latelet count‬ P ‭PT‬ ‭INR‬ ‭PTT‬ ‭CXR all pts (new‬ ‭patchy or diffuse‬ ‭opacities)‬ ‭Bronchoalveolar‬ ‭lavage‬ ‭ x underlying once‬ T ‭identified‬ ‭ emoptysis but may‬ H ‭be absent in ⅓ of pts‬ ‭ ulse oximetry‬ P ‭Glucose‬ ‭ABG‬ ‭Serum electrolytes‬ ‭CXR‬ ‭CBC‬ ‭D-Dimer‬ ‭ECG‬ ‭Toxicology scan‬ ‭ reat underlying‬ T ‭cause‬ ‭ABG‬ ‭ xygen‬ O ‭Hyperbaric oxygen if‬ ‭severe‬ ‭ yperventilation‬ H ‭syndrome‬ ‭ arbon monoxide‬ C ‭poisoning‬ I‭nflammatory causes:‬ A ‭ cute respiratory‬ ‭glucocorticoids w/‬ ‭distress‬ ‭immunosuppressive‬ ‭therapy‬ ‭Onset of new‬ ‭respiratory symptoms‬ ‭Hypoxemia: oxygen‬ ‭& ground glass or‬ ‭consolidative‬ ‭opacities‬ ‭Breathing retraining‬ ‭ nxiolytics (benzos‬ A ‭like lorazepam)‬ i‭f cyanide‬ ‭poisoning→‬ ‭hydroxocobalamin‬ ‭ bstructive sleep‬ O ‭apnea‬ ‭ ight time lab‬ N ‭polysomnography‬ ‭(O2 drops and an‬ ‭ECG can show‬ ‭bradyarrhythmias)‬ ‭ ild: 5 episodes‬ M ‭Moderate: 15-30‬ ‭episodes‬ ‭ nxiety disorders‬ A ‭Carpopedal spasm‬ ‭Slow or fast deep‬ ‭breaths‬ ‭ ires, intentional,‬ F ‭cars in garage‬ ‭ ie before reaching‬ D ‭hospital from‬ ‭ventricular‬ ‭arrhythmias‬ ‭ ifestyle‬ L ‭modifications (weight‬ ‭loss)‬ ‭Daytime fatigue‬ ‭ PAP (continuous‬ C ‭positive airway‬ ‭pressure)‬ ‭ bserved (partner‬ O ‭comes in with pt)‬ ‭Snoring‬ ‭HTN‬ ‭Tx underlying‬ ‭Severe: >30‬ ‭BMI 35 or greater‬ ‭ racheostomy (bed‬ T ‭bound pt)‬ ‭Over 50‬ ‭Male‬ ‭ eck circumference‬ N ‭> 40cm‬ ‭Central sleep apnea‬ ‭ ight time‬ N ‭polysomnography‬ ‭Primary CSA‬ ‭CPAP‬ ‭A fib‬ ‭ octurnal oxygen‬ N ‭therapy‬ ‭CHF‬ ‭Nocturnal angina‬ ‭ SA with cheyne‬ C ‭stokes breathing‬ ‭Similar OSA sx‬ ‭ on't use CPAP if EF‬ D ‭< 45% in CHF‬ ‭ besity‬ O ‭hypoventilation‬ ‭syndrome‬ ‭ABG (PaCO2 >45)‬ ‭Inhalation injury‬ ‭ erial CXR‬ S ‭Pulse oximetry (false‬ ‭elevated w/ carbon‬ ‭monoxide)‬ ‭ABG: can give you‬ ‭carboxyhemoglobin‬ ‭level‬ ‭ ositive airway‬ P ‭pressure therapy‬ ‭(CPAP,BiPAP)‬ ‭ ypoventilation in‬ H ‭obese pt during‬ ‭wakefulness‬ ‭ imit exposure,‬ L ‭remove pt‬ ‭ moke inhalation‬ S ‭exposed to fire‬ ‭ aintain secure‬ M ‭airway‬ ‭ oss of‬ L ‭consciousness‬ ‭ onsider early & pre‬ C ‭emptive intubation‬ ‭ triator or upper way‬ S ‭turbulence → prompt‬ ‭intubation‬ I‭n lab‬ ‭polysomnography (if‬ ‭not already‬ ‭Weight reduction‬ ‭diagnosed with OSA)‬ ‭Tx supportive‬ ‭ teroid use NOT‬ S ‭PROVEN‬ ‭BENEFICIAL‬ ‭ bx NOT‬ A ‭recommended‬ ‭ ydrogen cyanide‬ H ‭poisoning→‬ ‭hydroxocobalamin‬ ‭ arbonaceous‬ C ‭material in the mouth‬ ‭ oss of facial hair or‬ L ‭intranasal hair‬ ‭Facial burns‬ ‭Pre op care:‬ ‭MEDS USE SHOULD DISCONTINUE‬ ‭MEDS YOU DO NOT DISCONTINUE‬ ‭ lpha 1 blockers (consult opthalm)‬ A ‭Allopurinol‬ ‭Antiepileptic‬ ‭Antipsychotics, benzos, TCA, valproic acid,‬ ‭lithium‬ ‭levothyroxine , PTU, methimazole‬ ‭Oral contraceptives (low to mod risk of VTE)‬ ‭H2 blockers‬ ‭PPI‬ ‭Inhaled bronchodilators‬ ‭Baby aspirin (preference)‬ ‭Alpha 2 agonist‬ ‭Statins‬ ‭CCB‬ ‭BB‬ ‭ erbal meds‬ H ‭Colchicine (hold morning)‬ ‭Rheumatologic (determine by rheumatologist)‬ ‭Bisphosphonates‬ ‭Methylphenidate/ ADHD meds‬ ‭Opioids can take AM for pain otherwise hold‬ ‭SSRI‬ ‭Theophylline (evening)‬ ‭Oral contraceptives with high risk VTE (4‬ ‭weeks before)‬ ‭Clopidogrel (hold 7-10 days prior, consult‬ ‭cardio)‬ ‭NSAIDS (held 5 days before)‬ ‭Factor Xa inhibitors (2-3 days prior)‬ ‭Warfarin ( 5 days prior)‬ ‭Insulin (use half dose, long acting)‬ ‭Oral antidiabetic meds (hold AM)‬ ‭Niacin and fibrates (day before)‬ ‭Diuretics ( morning dose)‬ ‭ACE/ARB (10 hrs prior)‬ ‭‬ A ‭ dults and teens over 12 may have solid foods and dairy products until 8 hours before‬ ‭surgery, pt encouraged to drink clear liquids NOT milk or dairy until 2 hours before‬ ‭surgery time‬ ‭a.‬ E ‭ x of clear fluids: water, clear fruit juice (apple, white cranberry), plain tea or‬ ‭black coffee, clear electrolyte replenishing drinks, ensure clear‬ ‭‬ ‭RF for surgery:‬ ‭a.‬ ‭Age‬ ‭b.‬ ‭Alcohol misuse‬ ‭c.‬ ‭Smoking (stopping smoking within 8 weeks of surgery might worsen post op‬ ‭outcomes)‬ ‭d.‬ ‭Obesity not a risk factor for most major post op outcomes (increases rates for‬ ‭wound infection)‬ ‭Cardiac assessment:‬ ‭‬ ‭RCRI (revised cardiac risk index)‬ ‭a.‬ ‭6 element, each positive element increases odds of cardiac complication by a‬ ‭factor of 2 to 3 and more than one positive response indicated the patient is at‬ ‭high risk for complications: hx of ischemic heart disease, CHF, cerebrovascular‬ ‭disease tx with insulin, serum creaking >2.0, high risk surgery‬ ‭b.‬ ‭0 points→ 0.4%‬ ‭c.‬ ‭1 point→ 0.9%‬ ‭d.‬ ‭2 points→ 6.6%‬ ‭e.‬ ‭3 or more→ 11%‬ ‭‬ ‭ACS NSQUIP/SRC‬ ‭a.‬ ‭Subjective and unreliable‬ ‭‬ ‭RCRI score

Use Quizgecko on...
Browser
Browser